Sugi Predict

Sugi Predict / Compounds / SCHEMBL914548

SCHEMBL914548

SCHEMBL914548

COC(=O)c1ccc(-c2ccccc2Cl)c(-c2ccc(Cl)c(OCc3ccc(OC)cc3)c2)n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOTUM Q6P988 1/20 0.45
▸ KDM4E B2RXH2 3/20 0.43
▸ CYP1A2 P05177 2/20 0.43
▸ CYP2C9 P11712 2/20 0.43
▸ CYP2C19 P33261 2/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ CNR1 P21554 1/20 0.41
▸ PIK3CD O00329 2/20 0.41
▸ CTSA P10619 1/20 0.40
▸ MAPT P10636 2/20 0.40
▸ LMNA P02545 2/20 0.40
▸ POLB P06746 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ PKM P14618 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ DHODH Q02127 1/20 0.39
▸ PPARG P37231 1/20 0.39
▸ NPC1 O15118 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL912923 0.93 NOTUM (0.44) NOTUMKDM4ECYP1A2CYP2C9CYP2C19
SCHEMBL544928 0.93 NOTUM (0.52) NOTUMKDM4ECYP1A2CYP2C9CYP2C19
SCHEMBL2490382 0.92 KDM4E (0.43) NOTUMKDM4ECYP1A2CYP2C9CYP2C19
SCHEMBL544355 0.89 NOTUM (0.40) NOTUMKDM4ECYP1A2CYP2C9CYP2C19
SCHEMBL913698 0.87 NOTUM (0.45) NOTUMKDM4ECYP1A2CYP2C9CYP2C19
SCHEMBL913482 0.86 CNR1 (0.40) NOTUMKDM4ECYP1A2CYP2C9CYP2C19
SCHEMBL544584 0.85 NOTUM (0.51) NOTUMKDM4ECNR1CTSAMAPT
SCHEMBL912835 0.85 NOTUM (0.40) NOTUMKDM4ECYP1A2CYP2C9CYP2C19
SCHEMBL2491639 0.85 MCL1 (0.43) NOTUMKDM4ECYP1A2CYP2C9CYP2C19
SCHEMBL27751889 0.83 NOTUM (0.49) NOTUMKDM4ECYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8653276-B2 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation thereof and therapeutic application thereof as urotensin II receptor antagonists SANOFI (FR) 2014-02-18 — — US disclosed
US-20130252974-A1 5,6-BISARYL-2-PYRIDINE-CARBOXAMIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC APPLICATION THEREOF AS UROTENSIN II RECEPTOR ANTAGONISTS SANOFI (FR) 2013-09-26 — — US disclosed
US-8466292-B2 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation thereof and therapeutic application thereof as urotensin II receptor antagonists SANOFI (FR) 2013-06-18 — — US disclosed
US-20110009426-A1 5,6-BISARYL-2-PYRIDINE-CARBOXAMIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC APPLICATION THEREOF AS UROTENSIN II RECEPTOR ANTAGONISTS SANOFI-AVENTIS (FR) 2011-01-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110009426-A1 5,6-BISARYL-2-PYRIDINE-CARBOXAMIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC APPLICATION THEREOF AS UROTENSIN II RECEPTOR ANTAGONISTS UTS2R, PLAUR, NTSR2 NOTUM 2370/4885KDM4E 3689/4885CYP1A2 2043/4885
US-20130252974-A1 5,6-BISARYL-2-PYRIDINE-CARBOXAMIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC APPLICATION THEREOF AS UROTENSIN II RECEPTOR ANTAGONISTS UTS2R, PLAUR, NTSR2 NOTUM 2370/4885KDM4E 3689/4885CYP1A2 2043/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.